Browse grants
Federal opportunities with plain-English eligibility summaries. We aggregate public records — always verify the details on the funder’s site before applying.
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
Due Jan 7, 2028National Institutes of Health · Amount varies
An NIH/NIMH research project grant (R01, clinical trial required) funding effectiveness trials of post-acute therapeutic and service-delivery interventions for mental health conditions across the lifespan. A broad set of domestic and foreign institutions may apply, including universities, tribal governments, and faith- or community-based organizations. No specific award ceiling is stated. This requires conducting a clinical trial, so it suits research institutions with that capacity rather than individuals or general nonprofits.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreNeuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH R21 supports research teams developing the next generation of brain stimulation (neuromodulation/neurostimulation) devices for treating mental health disorders, either creating novel devices or substantially enhancing FDA-approved/cleared ones. Eligible applicants include universities, nonprofits, governments, tribal organizations, and a wide range of institutions; applications should come from multidisciplinary teams spanning neuroscience, engineering, clinical, and regulatory expertise. Incremental software-only updates to existing devices are out of scope, and clinical trials are not allowed under this announcement. The award amount is not specified and the deadline is in 2028.
ResearchersNonprofitsSchools & universitiesGovernment / tribal+2 moreDoW’s Energy, Installations, and Environment Innovation Partners Programs
Due Jan 8, 2028Washington Headquarters Services · $0–$100M
A Department of War (Washington Headquarters Services) non-research cooperative agreement program to help manage and sustain DoW land in the U.S. through natural and cultural resource projects supporting installation resilience and military readiness. Eligibility is very broad: public and private agencies, organizations, institutions, and individuals are invited to apply. Awards range widely, up to about $100 million. The broad eligibility, including individuals, is unusual, so confirm specific requirements in the announcement.
NonprofitsSmall businessResearchersIndividuals+4 moreBlueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
Due Jan 28, 2028National Institutes of Health · Amount varies
The Blueprint MedTech Translator (NIH UG3/UH3) funds translational work and clinical feasibility studies to develop therapeutic and diagnostic devices for nervous-system and neuromuscular disorders, including prototype implementation, safety/efficacy testing, and obtaining FDA IDE or IRB approval. It is a milestone-driven cooperative agreement with active NIH staff involvement, and awardees also receive consultant support on regulatory, IP, and commercialization matters. Eligibility is broad, including universities, nonprofits, businesses, tribal governments, and individuals developing their own devices. The award amount is not specified and the deadline is in 2028.
ResearchersNonprofitsSmall businessSchools & universities+3 moreReissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Due Feb 8, 2028Food and Drug Administration · $0–$600K
This FDA R01 funds efficient, innovative natural history studies that advance medical product development for rare diseases with unmet needs, aiming to fill knowledge gaps and accelerate product development. Eligibility is very broad, including universities, nonprofits, for-profit and small businesses, state/local/tribal governments, and, unusually, foreign (non-U.S.) organizations, which are eligible to apply. Clinical trials are optional, the maximum award is about $600,000, and the deadline is in 2028.
ResearchersNonprofitsSmall businessSchools & universities+3 moreReissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Due May 16, 2028Food and Drug Administration · $0–$900K
Open to nearly any organization — universities, nonprofits (with or without 501(c)(3)), for-profits and small businesses, state/local/tribal governments, and foreign organizations. This FDA R01 funds clinical trials of orphan products evaluating safety and efficacy to address unmet needs in rare diseases. Awards up to about $900,000; clinical trials are required.
ResearchersNonprofitsSmall businessGovernment / tribal+3 moreBROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
Due Jul 31, 2028Defense Health Agency Contracting Activity - DHACA · $750K–$50M
Open broadly to any type of entity — universities, nonprofits, businesses (including small businesses), and others. This Department of Defense / Defense Health Agency broad agency announcement funds extramural biomedical and human-performance research and development through FY28. Awards span a very wide range, from about $750,000 to $50 million.
ResearchersNonprofitsSmall businessSchools & universities+3 moreDefense Security Cooperation University - Research Grants
Due Aug 7, 2028Washington Headquarters Services · $2.5K–$800K
This Defense Security Cooperation University program funds research that builds knowledge on security cooperation and irregular warfare, with all research products required to be unclassified and publicly accessible. Eligibility is broad and unusual: individual researchers or teams (with or without affiliation), military and civilian academic institutions, U.S. and international research and think-tank institutions, FFRDCs, and security cooperation communities of interest may apply, though some components have restrictions and applicants may submit only one proposal at a time. Awards range from about $2,500 up to $800,000, and the deadline is in 2028.
ResearchersIndividualsSchools & universitiesGovernment / tribal+2 moreVet-LIRN Capacity-Building Project and Equipment Grants (U18)
Due Sep 4, 2028Food and Drug Administration · $225K–$2.5M
This FDA Vet-LIRN program funds veterinary diagnostic laboratories in the Vet-LIRN network for capacity-building projects and equipment, supporting work on animal food safety, antimicrobial resistance, and One Health initiatives. A broad range of applicants is eligible, including public and private institutions of higher education, state, local, and tribal governments, small businesses, for-profits, and nonprofits with or without 501(c)(3) status. Awards range from about $225,000 up to $2.5 million, but applicants generally must be part of or able to join the Vet-LIRN veterinary diagnostic laboratory network.
NonprofitsSmall businessSchools & universitiesGovernment / tribal+3 moreUsing Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)
Due Oct 20, 2028National Institutes of Health · Up to $200K
This NIH R21 grant funds secondary analyses that use archived HIV/AIDS data sets and specimen collections to answer questions about maternal, pediatric, and adolescent HIV/AIDS. Both U.S. and foreign organizations are eligible to apply, but foreign components within a project are not allowed. The award ceiling is up to about $200,000.
ResearchersSchools & universitiesBroad eligibilityData Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
Due Nov 2, 2028National Institutes of Health · Amount varies
This NIH/NHLBI U24 cooperative agreement funds a Data Coordinating Center to provide data management, biostatistics, and project coordination for investigator-initiated multi-site clinical trials. A companion Clinical Coordinating Center application must be submitted on the same due date for consideration. Both U.S. and foreign organizations may apply, but applications with funded foreign subawards/subcontracts will be rejected.
ResearchersSchools & universitiesBroad eligibilitySingle-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
Due Nov 2, 2028National Institutes of Health · Amount varies
This NIH/NHLBI R61/R33 cooperative agreement funds investigator-initiated single-site clinical trials relevant to the NHLBI mission, using a milestone-driven, two-phase structure. Both U.S. and foreign organizations may apply, but applications including funded foreign subawards/subcontracts will be deemed noncompliant. Applicants are encouraged to include expertise in biostatistics and clinical trial design.
ResearchersSchools & universitiesBroad eligibilityClinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
Due Nov 2, 2028National Institutes of Health · Amount varies
This NIH/NHLBI UG3/UH3 cooperative agreement funds a Clinical Coordinating Center to lead and operate investigator-initiated multi-site clinical trials relevant to the NHLBI mission. A companion Data Coordinating Center application must be submitted on the same due date. Both U.S. and foreign organizations may apply, but applications with funded foreign subawards/subcontracts will be rejected.
ResearchersSchools & universitiesBroad eligibilityEarly Immune System Development and Ontogeny (R01 Clinical Trial Optional)
Due Nov 5, 2028National Institutes of Health · Up to $400K
This NIH R01 grant funds research into early immune system development from the prenatal period through early childhood, including effects of in-utero HIV or antiretroviral exposure. A broad range of applicants is eligible, including colleges and universities, tribal governments, faith- and community-based organizations, minority-serving institutions, and foreign organizations. The award ceiling is up to about $400,000.
ResearchersSchools & universitiesNonprofitsGovernment / tribal+1 moreThe Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
Due Nov 22, 2028National Institutes of Health · Up to $500K
This NIH/NCI U01 cooperative agreement funds research projects within the Metastasis Research Network that use systems-level approaches to study cancer metastasis as a whole-body problem. Both U.S. and foreign organizations may apply, but applications including funded foreign subawards/subcontracts will be deemed noncompliant. The award ceiling is up to about $500,000.
ResearchersSchools & universitiesLarge awardBroad eligibilityResearch Grants in Clinical Informatics (R01 Clinical Trial Optional)
Due Mar 5, 2029National Institutes of Health · $0–$250K
This NIH/NLM R01 grant funds research teams developing and evaluating clinical informatics tools and methods that turn health data (such as electronic health records, clinical notes, and imaging) into actionable knowledge. Both U.S. and foreign organizations are eligible to apply, but applications involving funded foreign subawards/subcontracts will be rejected under NIH's post-May-2025 policy. The award ceiling is up to about $250,000.
ResearchersSchools & universitiesBroad eligibilityAdvancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)
Due Mar 5, 2029National Institutes of Health · Up to $250K
This NIH/NLM R01 grant supports research advancing bioinformatics, translational bioinformatics, and computational biology, including AI and machine-learning methods for interpreting large biological datasets. Both U.S. and foreign organizations may apply, but applications that include funded foreign subawards/subcontracts will be deemed noncompliant and not considered. The award ceiling is up to about $250,000.
ResearchersSchools & universitiesBroad eligibilityARMY APPLICATIONS LAB BROAD AGENCY ANNOUNCEMENT FOR DISRUPTIVE APPLICATIONS
Due Apr 4, 2029Dept of the Army -- Materiel Command · Amount varies
The Army Applications Lab Broad Agency Announcement funds basic and applied scientific research in defense-relevant areas described in the BAA. Eligibility is unusually broad: institutions of higher education, nonprofits, state and local governments, foreign organizations and public entities, and for-profit businesses (large and small) may all apply. No specific award amount is listed, and projects are selected through full and open competition, so applicants should review the BAA's stated research areas of interest.
ResearchersSmall businessNonprofitsSchools & universities+2 moreCHIPS Research and Development Office (CRDO) Broad Agency Announcement (BAA)
Due Sep 30, 2029National Institute of Standards and Technology · From $10M
This NIST CHIPS R&D Office Broad Agency Announcement funds research, prototyping, and commercial solutions that advance U.S. microelectronics technology, with a stated floor of about $10 million per award. Eligible applicants include for-profit and non-profit organizations, accredited universities, FFRDCs, and federal entities, but they must be domestic; individuals and unincorporated sole proprietors are not eligible. Some foreign partners may participate as subawardees, subject to restrictions (foreign adversaries excluded). Given the large award size, applicants should review the full BAA for compliance requirements.
Small businessNonprofitsSchools & universitiesResearchers+3 moreAir Dominance Broad Agency Announcement (BAA)
Due Oct 31, 2029Munitions Directorate · Up to $750M
This Air Force (Munitions Directorate) Broad Agency Announcement funds research and development supporting air dominance, with a program ceiling reported up to roughly $750 million. Eligibility is described as unrestricted and open to any type of entity, subject to any clarifications in the full announcement, making it broadly accessible to businesses, universities, and nonprofits. Because it is defense-focused R&D, applicants should expect security and compliance requirements and should review the full BAA for specifics.
ResearchersSmall businessNonprofitsSchools & universities+3 more